Astrana Health, Inc. (ASTH) SEC filings

ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/307% below fair value

$31.80+0.03 (+0.09%)

Close on Nov 13, 2026Market cap $1.77BP/E 29.7Yield –

SEC filings

40 of Astrana Health's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 6, 2026	SEC EDGAR
Current report	8-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Sep 23, 2026	Sep 23, 2026	SEC EDGAR
Current report	8-K	Sep 22, 2026	Sep 23, 2026	SEC EDGAR
Current report	8-K	Sep 15, 2026	Sep 15, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 10, 2026	SEC EDGAR
Current report	8-K	Aug 6, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Jul 13, 2026	Jul 13, 2026	SEC EDGAR
Current report	8-K	Jun 25, 2026	Jul 1, 2026	SEC EDGAR
Current report	8-K	Jun 10, 2026	Jun 10, 2026	SEC EDGAR
Current report	8-K	May 7, 2026	May 12, 2026	SEC EDGAR
Current report	8-K	May 12, 2026	May 12, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 8, 2026	SEC EDGAR
Current report	8-K	May 7, 2026	May 7, 2026	SEC EDGAR
Proxy statement	DEF 14A	Jun 10, 2026	Apr 17, 2026	SEC EDGAR
Current report	8-K	Mar 30, 2026	Mar 30, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 12, 2026	SEC EDGAR
Current report	8-K	Mar 4, 2026	Mar 4, 2026	SEC EDGAR
Current report	8-K	Mar 2, 2026	Mar 2, 2026	SEC EDGAR
Current report	8-K	Jan 12, 2026	Jan 12, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 10, 2025	SEC EDGAR
Current report	8-K	Nov 6, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Aug 7, 2025	Aug 7, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 7, 2025	SEC EDGAR
Current report	8-K	Jul 1, 2025	Jul 2, 2025	SEC EDGAR
Current report	8-K	Jun 11, 2025	Jun 11, 2025	SEC EDGAR
Current report	8-K	Jun 4, 2025	Jun 4, 2025	SEC EDGAR
Current report	8-K	May 13, 2025	May 13, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 9, 2025	SEC EDGAR
Current report	8-K	May 8, 2025	May 8, 2025	SEC EDGAR
Proxy statement	DEF 14A	Jun 11, 2025	Apr 25, 2025	SEC EDGAR
Current report	8-K	Mar 26, 2025	Mar 28, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Mar 14, 2025	SEC EDGAR
Current report	8-K	Mar 10, 2025	Mar 10, 2025	SEC EDGAR
Current report	8-K	Mar 3, 2025	Mar 3, 2025	SEC EDGAR
Current report	8-K	Feb 27, 2025	Feb 27, 2025	SEC EDGAR
Current report	8-K	Feb 26, 2025	Feb 27, 2025	SEC EDGAR
Current report	8-K	Jan 17, 2025	Jan 21, 2025	SEC EDGAR
Current report	8-K	Jan 14, 2025	Jan 14, 2025	SEC EDGAR
Current report	8-K	Nov 14, 2024	Nov 14, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Astrana Health's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Apr 27, 2015
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ASTH.

Compare: ASTH vs EVH · ASTH vs HURN · ASTH vs FCN · ASTH vs G · ASTH vs ICFI

Revenue growth35.1% · median 7.8%

Gross margin11.0% · median 34.0%

Operating margin3.1% · median 8.8%

Net margin1.4% · median 5.9%

Company	Revenue	Growth
G	$5.34B	+6.7%
FCN	$3.98B	+7.8%
ASTH	$3.91B	+35.1%
EVH	$2.34B	+14.1%
ICFI	$1.83B	-5.2%
HURN	$1.81B	+13.6%

Company

Next earnings (est.): Mar 1, 2027, before open
Exchange: Nasdaq
Industry: Services-Management Consulting Services
Fiscal year ends: December 31
Employees: 3,000
Held by institutions: 57.7%
Auditor: Ernst & Young LLP
SEC CIK: 1083446

Advertisement
300 × 250

See a number that looks wrong?